||
The global anti-inflammatory drugs market size reached USD 111.42 Billion in 2021 and is expected to register a revenue CAGR of 9.3% during the forecast period, according to latest analysis by Emergen Research. Potential pipeline candidates is the main factor driving the market revenue growth. For instance, the monoclonal antibody mirikizumab (LY3074828) fulfilled the primary and all significant secondary objectives in the LUCENT-1 ulcerative colitis Phase 3 study, according to a March announcement from Lilly. The drug's potential as a therapy for moderate to severe ulcerative colitis was assessed throughout the 12-week multicenter induction phase. The humanized monoclonal antibody attaches to the interleukin-23 p19 subunit (IL-23p19). A cytokine that promotes inflammation is interleukin-23. In March, Lilly bragged that the Phase 3 trial LUCENT-1, which used an anti-IL-23p19 monoclonal antibody, was the only one to show a reduction in bowel urgency in patients with moderate to severe ulcerative colitis. Mirikizumab can be used to treat ulcerative colitis and crohn's disease, according to Lilly.
The market intelligence report offers a panoramic view of the global Anti Inflammatory Drugs industry, with a special focus on the regional bifurcation and competitive landscape. Crucial information pertinent to the latest industrial growth trends, technological advancements, product offerings, production capacity, demand and supply ratio, and estimated growth rate have been included in this report. The research methodologies offered in the report are intended to help readers gain a competitive edge in the market. Additionally, the report undertakes the SWOT Analysis and Porter’s Five Forces Analysis to assess the market standing of the leading companies operating in this sector.
Get Free Exclusive Sample PDF Copy: @https://www.emergenresearch.com/request-sample/1299
Key Players operating in the industry are:
AbbVie Inc., Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., Novartis AG, GSK plc, Lilly, Amgen Inc., Biogen
Radical Features of the Anti Inflammatory Drugs Market Report:
Request customization of the report @https://www.emergenresearch.com/request-history/1299
Segmentation:
Regional Analysis Covers:
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/anti-inflammatory-drugs-market
Thank you for reading our report. To request a customization or for further inquiries, kindly get in touch with us. Our team will ensure the report is tailored meet to your needs.
Read similar reports by Emergen Research:
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
ติดต่อผู้ดูแลเว็บไซต์ได้ที่ webdungdong@gmail.com|บริษัท ดั้งโด่งดอทคอม จำกัด|ติดต่อลงโฆษณา| ดั้งโด่งดอทคอม@2020
Copyright © 2001-2013 Comsenz Inc. All Rights Reserved. Powered by Discuz! X3.2 R20140618, Rev.27, Thzaa City 1 Style